As the cost of living crisis deepens, you may be assessing your regular monthly outgoings and looking for …
Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it into increasingly buzzy areas of healthcare, from longevity research to aesthetic medicine. “We have to be …
